Company Overview

Development Stage

About the Company

[Summary] Guangdong Provincial Engineering Technology Research Center for Cardio

Hunan Nanxin Pharmaceutical Joint-stock Co., Ltd. is a holding subsidiary of Hunan Pharmaceutical Development Investment Group Co., Ltd. Founded in 2006 with a registered capital of 274 million yuan, it was listed on the Science and Technology Innovation Board in 2020 (stock code: 688189). The company focuses on the research and development of anti-infective, cardiovascular and cerebrovascular, and antipyretic and analgesic drugs, holding 16 new drug certificates and over 10 patents, and has in-depth cooperation with institutions such as the Academy of Military Medical Sciences. It holds 2 drug production licenses, 4 GMP certifications, and 62 production approvals. With 4 subsidiaries, its annual production capacity includes 12.25 million bottles of infusion and 650 million tablets/capsules of solid preparations, ranking among the top in the industry in terms of quality and scale.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (32 open positions)

Manage
Note: How fast is hiring at Guangzhou Nanxin Pharmaceutical Co., Ltd. growing? 2025: 77 openings (up 103%), 2024: 38 openings (down 66%), 2023: 111 openings (up 79%), 2022: 62 openings (down 62%), 2021: 162 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Guangzhou Nanxin Pharmaceutical Co., Ltd. growing? Master's recruitment over the years: 2025: 4 openings (up 103%), 2023: 16 openings (up 79%), 2022: 17 openings (down 62%), 2021: 16 openings.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2025 — 1 fewer jobs than 2024
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Guangzhou Nanxin Pharmaceutical Co., Ltd. growing? Doctorate recruitment over the years: 2025: 1 openings (up 103%), 2024: 2 openings (down 66%), 2023: 7 openings (up 79%), 2022: 3 openings (down 62%), 2021: 3 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Guangzhou Nanxin Pharmaceutical Co., Ltd.? Based on an analysis of 's job postings over the past year, "生物/制药/化工/环保类" demand: 15.8%, "医疗卫生/美容保健类": 10.5%, "机械/仪器仪表类": 1.3%. For reference only.

— What Are the Salaries Like? (76 records)

Manage
salary range: 4.5K - 50K, 92.1% of roles pay ¥6-15K
Note: salary statistics are based on 76 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Guangzhou Nanxin Pharmaceutical Co., Ltd.?92.1% of positions earn 6-15K, Fresh graduate salary: ¥7.0K。经营管理类 average salary ¥12.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Guangzhou Nanxin Pharmaceutical Co., Ltd.? We provide: 总经理,招商,省区负责人,分析,管培生,运营,临床,医学经理,法务,行政,qa,qc,ra,党务,内审,医学专员,安全,客服,并购,战略投资. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 经营管理类
    59.7% of total 59.7%
  • 销售类
    20.8% of total 20.8%
  • 生物/制药/化工/环保类
    15.6% of total 15.6%
  • 医疗卫生/美容保健类
    10.4% of total 10.4%

Education

  • 本科
    85.7% of total 85.7%
  • 不限
    7.8% of total 7.8%
  • 硕士
    5.2% of total 5.2%
  • 高中
    1.3% of total 1.3%

Experience

  • 不限
    44.2% of total 44.2%
  • 5-10年
    40.3% of total 40.3%
  • 1-3年
    6.5% of total 6.5%
  • 3-5年
    5.2% of total 5.2%
View Detailed Analysis

What does Guangzhou Nanxin Pharmaceutical Co., Ltd. require? Who is Guangzhou Nanxin Pharmaceutical Co., Ltd. hiring? recruitment: 经营管理类占比最多占59.7%,其次是销售类占20.8%. What education can get in at ? 本科占比最多占85.7%,其次是不限占7.8%. High education required at ? 硕士占5.2%. Work experience required at ? 不限占比最多占44.2%,其次是5-10年占40.3%. Where are the job locations at ? 广州占比最多占58.4%,其次是郑州占5.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,525万(元)
Legal Representative: 周祥
Date Established:
Credit Code: 91440101618440809W
Registered Address: 广州市萝岗区开源大道196号自编1-2栋

Partners & Suppliers

南京医药是南新制药的经销商,主要在华东地区销售南新制药的产品。 Source
合作客户 药品经销/配送
九州通是南新制药的经销商,采购其药品并通过自有渠道分销。 Source
合作客户 药品经销/配送
上海医药是南新制药的经销商,负责上海及周边地区的药品配送和销售。 Source
合作客户 药品经销/配送
华润医药是南新制药的经销商,采购南新制药的药品并通过其分销网络销售。 Source
合作客户 药品经销/配送
国药控股是南新制药的主要经销商之一,负责南新制药产品(如帕拉米韦注射液)的全国分销和医院准入。 Source
合作客户 药品经销/配送

People who follow this company also follow

Competitors (Similar Companies)

制药/药业 生物医药 生物制药 生物化学
“努力把中沃打造成国内甚至国际化的驰名品牌”
“Products for the diagnosis and treatment of allergic diseases”
新材料 乳胶制品 材料研发 天然橡胶
“主营医药中间体、原料药和成品药的研发、生产与销售”
“Professional production of automotive seat headrests and armrests”
“A domestic first-class, internationally renowned biotechnology enterpr”
“Home furnishing brand operator”
“供应链管理及综合物流服务商”
传感器 控制设备 记录仪 系统集成
“一家专业的综合型人力资源外包服务商”
制冷 压缩机 精密铸造 空调压缩机
汽车零部件/配件 轮胎 工厂 工业
“Steroid APIs and preparations. Produce first-class products, committed”
钢结构工程 复合板 建筑施工 工程施工

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates